SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
-1.29%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$664M
AUM Growth
+$664M
(-45%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-73.97%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$10.8M |
| 2 |
Privia Health
PRVA
|
$10.4M |
| 3 |
Certara
CERT
|
$9.96M |
| 4 |
Definitive Healthcare
DH
|
$7.8M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$7.05M |
Top Sells
| 1 |
Arcus Biosciences
RCUS
|
$18.4M |
| 2 |
Agilent Technologies
A
|
$18.4M |
| 3 |
ResMed
RMD
|
$15.8M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$15.5M |
| 5 |
Icon
ICLR
|
$13.8M |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Certara
CERT
$1.69B
| $9.96M | 1.5% |
+350,438
| New | +$9.96M |
|
27
Abbott
ABT
$230B
| $9.65M | 1.45% |
68,548
-5,900
| -8% | -$830K |
|
28
Health Catalyst
HCAT
$228M
| $9.58M | 1.44% |
241,739
-199,261
| -45% | -$7.89M |
|
29
AbbVie
ABBV
$374B
| $9.32M | 1.4% |
68,800
-20,200
| -23% | -$2.74M |
|
|
SILK
30
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.91M | 1.34% |
209,000
-215,500
| -51% | -$9.18M |
|
31
Intellia Therapeutics
NTLA
$1.26B
| $8.47M | 1.27% |
71,600
+8,700
| +14% | +$1.03M |
|
32
Denali Therapeutics
DNLI
$2.24B
| $8.46M | 1.27% |
189,600
+62,100
| +49% | +$2.77M |
|
33
Rocket Pharmaceuticals
RCKT
$358M
| $8.36M | 1.26% |
382,975
-123,110
| -24% | -$2.69M |
|
34
Eli Lilly
LLY
$661B
| $8.14M | 1.22% |
29,465
-11,250
| -28% | -$3.11M |
|
|
35
Definitive Healthcare
DH
$405M
| $7.8M | 1.17% |
+285,299
| New | +$7.8M |
|
36
TG Therapeutics
TGTX
$5.03B
| $7.6M | 1.14% |
399,949
+5,000
| +1% | +$95K |
|
37
Exelixis
EXEL
$9.95B
| $7.49M | 1.13% |
409,940
+26,570
| +7% | +$486K |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $7.05M | 1.06% |
+65,800
| New | +$7.05M |
|
39
Arrowhead Research
ARWR
$3.84B
| $6.95M | 1.05% |
+104,800
| New | +$6.95M |
|
40
Novavax
NVAX
$1.2B
| $6.34M | 0.95% |
44,300
-45,150
| -50% | -$6.46M |
|
|
NVTA
41
DELISTED
Invitae Corporation
NVTA
| $6.27M | 0.94% |
410,763
| – | – |
|
|
SWAV
42
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.24M | 0.94% |
35,000
+7,000
| +25% | +$1.25M |
|
|
EXAI
43
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $5.96M | 0.9% |
+301,433
| New | +$5.96M |
|
|
BLU
44
DELISTED
BELLUS Health Inc.
BLU
| $5.81M | 0.87% |
721,966
-1,216,938
| -63% | -$9.8M |
|
|
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.71M | 0.86% |
36,930
-61,176
| -62% | -$9.46M |
|
46
STAAR Surgical
STAA
$1.35B
| $5.71M | 0.86% |
62,500
+15,200
| +32% | +$1.39M |
|
47
Boston Scientific
BSX
$159B
| $5.53M | 0.83% |
130,226
+4,250
| +3% | +$181K |
|
48
Danaher
DHR
$143B
| $5.52M | 0.83% |
16,775
| – | – |
|
49
Align Technology
ALGN
$9.59B
| $5.43M | 0.82% |
8,265
-10,510
| -56% | -$6.91M |
|
|
CELL
50
DELISTED
PhenomeX Inc. Common Stock
CELL
| $5.31M | 0.8% |
291,835
-129,700
| -31% | -$2.36M |
|